Chapter 17

Lili Kuo, Research Scientist: LinkedIn Employment History, as of Oct. 2021.

Lili Kuo et al., “Retargeting of Coronavirus by Substitution of the Spike Glycoprotein Ectodomain: Crossing the Host Cell Species Barrier,” J Virol 7, no. 3 (2000): 1393-1406, doi: 10.1128/JVI.74.3.1393-1406.2000.

Avi Kapach, “Chimera,” Mythopedia, Dec. 7, 2022.

Frank J. Lebeda, George Koch, and Luther E. Lindler, Biological Weapons Defense: Infectious Disease and Counterbioterrorism (Humana Press, 2005), V.

US Congress, House, Committee on Homeland Security, Towards a National Biodefense Strategy, 108th Cong., 2nd sess., 2004, 41–43.

Charles Piller, “Biodefense Lab on the Defensive,” Los Angeles Times, Feb. 12, 2003.

Aidan McCarty, “Changes in US Biosecurity Following the 2001 Anthrax Attacks,” Journal of Bioterrorism & Biodefense 9, no. 2 (2018), doi: 10.4172/2157-2526.1000163.

David R. Franz, “The Dual Use Dilemma: Crying Out for Leadership,” St. Louis University Journal of Health Law and Policy 7, no. 1 (2013).

Crystal Franco and Tara Kirk Sell, “Federal Agency Biodefense Funding, FY2010-FY2011,” Biosecurity and Bioterrorism: Biodefense Strategy, Practice, and Science 8, no. 2 (2010): 129-149, doi: 10.1089=bsp.2010.0013.

Department of Health and Human Services, “Public Health and Social Services Emergency Fund Fiscal Year 2023,” 2023.

“Centers for Disease Control and Prevention FY 2024 President’s Budget,” CDC, accessed Jul. 18, 2023.

“FY 2024 Congressional Justification,” CDC, Mar. 13, 2023, accessed Jul. 18, 2023.

Ashley Rindsberg, “How Dick Cheney Created Anthony Fauci,” UnHerd, Aug. 29, 2022.

“President Delivers ‘State of the Union’,” The White House, Jan. 28, 2003.

W. J. Hennigan, “The U.S. Spent Billions of Dollars on Biodefense. COVID-19 Was the Attack It Never Saw Coming,” TIME, Oct. 9, 2020.

Jon Cohen and Eliot Marshall, “Vaccines for Biodefense: A System in Distress,” Science 294, no. 5542 (2001): 498-501, doi: 10.1126/science.294.5542.498.

Department of Defense, Department of Defense FY 2003 Budget Estimates, Feb. 2002, 136-137.

Robert F. Kennedy Jr., Private Interview with Paul D. Thacker.

National Institutes of Health, “NIAID Strategic Plan for Biodefense Research,” USDHHS, Feb. 2002.

“Emergency Preparedness and Response—Bioterrorism Agents/Diseases,” Centers for Disease Control and Prevention, Apr. 4, 2018.

“Universal Flu Vaccine,” C-SPAN, Oct. 29, 2019.

John Dudley Miller, “Postal Anthrax Aftermath: Has Bio-Defense Spending Made Us Safer?” Scientific American, Nov. 1, 2008.

Ibid.

“Biodefense and Related Programs,” National Institute of Allergy and Infectious Diseases, 2003.

Becky Little, “SARS Pandemic: How the Virus Spread around the World in 2003,” History, May 5, 2023.

Joel Achenbach, “What We Know about the Origin of Covid-19, and What Remains a Mystery,” Washington Post, Feb. 28, 2023.

Becky Little, “SARS Pandemic: How the Virus Spread around the World in 2003,” History, May 5, 2023.

Robert Walgate, “SARS Escaped a Beijing Lab Twice,” Genome Biology 4, spotlight-20040427-03 (2004), doi: 10.1186/gb-spotlight-20040427-03.

Robert F. Kennedy Jr., Private Interview with Miles Yu, August 2023.

“Frequently Asked Questions about SARS,” Centers for Disease Control and Prevention, Mar. 3, 2005.